Veeva

Join Veeva and Convatec to learn how a new approach to ePRO can simplify the study build to reduce cost and accelerate go-live. Hear first-hand how Convatec completed study builds in less than 2 weeks and how pharma can mirror this approach for their studies.

https://www.appliedclinicaltrialsonline.com/act_w/epro-delivery

Traditional ePRO approaches result in time-consuming study builds. Assessments must be configured and validated for every new study, even when reusing instruments in the same therapeutic area. This increases costs and restricts ePRO use.

During this session, discover how a new approach to ePRO can simplify the study build process, reduce implementation costs, and accelerate study go-live. Sandra Spencer-Duggan, Data Manager Medical and Clinical Affairs, Convatec will share her experience of implementing ePRO in a fast-paced MedTech environment, where cost and build timelines had previously prevented the use of ePRO solutions. Kieran Connolly, Senior Director MyVeeva Strategy, Veeva will then explore how the approach taken can be applied to conventional pharma studies.

Why traditional ePRO approaches will always limit how fast studies can be built

How a new approach enabled Convatec to implement new studies within 2 weeks

How these lessons can be applied to traditional pharma studies



Clinical Operations and ePRO/eCOA professionals from pharmaceutical/biotech companies, MedTech, and CROs.


Data Manager Medical and Clinical Affairs
Convatec

Sandra Spencer-Duggan is a Study Designer and Data Manager within the clinical operations team at Convatec, a MedTech business focused on solutions for chronic care. She is responsible for the day-to-day management and oversight of data management activities for clinical studies, including CROs, and has helped Convatec build their Clinical Data Management processes.
Sandra works hard to drive a culture of innovation within the clinical operations team, including active participation in the implementation of new clinical trial systems such as Veeva Vault.




Senior Director MyVeeva Strategy
Veeva

Kieran Connolly is Senior Director of MyVeeva Strategy at Veeva where he is responsible for strategies spanning digital trials, decentralized clinical trials, and patient technologies. Kieran has had a long career in clinical trial technology. Prior to joining Veeva in 2020, Kieran spent 15 years at Parexel where he held a variety of positions including establishing Parexel’s IRT client services team in California, 3 years in Shanghai leading the Parexel Informatics APAC business unit, and most recently as a senior technology leader on sponsor engagements for eClinical and decentralized trials technologies.




Senior Consultant
Veeva

Jack Bolton is a Senior Consultant at Veeva, specializing in ePRO delivery and client engagement for ePRO and eConsent programs. He is a project management professional with a strong background in software and clinical trial project delivery. Jack has held a variety of roles across vendors, sponsors, and sites. This gives him a broad understanding of the needs of all stakeholders to ensure successful implementation from inception through adoption to use by trial participants.

Webcasts

Webinar Date/Time:
Tue, May 23, 2023 11:00 AM EDT

Rethinking ePRO Delivery: How to Build Studies Faster and Smarter

Articles

Read this whitepaper to learn about key considerations pharmacovigilance teams examine when evaluating new safety solutions. 

How Modern Safety Solutions are Scaling Pharmacovigilance

Insmed had a late-breaking strategy change that challenged their timelines. Learn how they incorporated significant protocol changes and still hit their FPI deadline.


Veeva

Articles

Rethinking ePRO Delivery: How to Build Studies Faster and Smarter

How Modern Safety Solutions are Scaling Pharmacovigilance

Insmed’s Fast and Successful Study Builds